Risk of second cancer from scattered radiation of intensity-modulated radiotherapies with lung cancer

PurposeTo compare the risk of secondary cancer from scattered and leakage doses following intensity-modulated radiotherapy (IMRT), volumetric arc therapy (VMAT) and tomotherapy (TOMO) in patients with lung cancer.MethodsIMRT, VMAT and TOMO were planned for five lung cancer patients. Organ equivalent doses (OEDs) are estimated from the measured corresponding secondary doses during irradiation at various points 20 to 80 cm from the iso-center by using radio-photoluminescence glass dosimeter (RPLGD).ResultsThe secondary dose per Gy from IMRT, VMAT and TOMO for lung cancer, measured 20 to 80 cm from the iso-center, are 0.02~2.03, 0.03~1.35 and 0.04~0.46 cGy, respectively. The mean values of relative OED of secondary dose of VMAT and TOMO, which is normalized by IMRT, ranged between 88.63% and 41.59% revealing 88.63% and 41.59% for thyroid, 82.33% and 41.85% for pancreas, 77.97% and 49.41% for bowel, 73.42% and 72.55% for rectum, 74.16% and 81.51% for prostate. The secondary dose and OED from TOMO became similar to those from IMRT and VMAT as the distance from the field edge increased.ConclusionsOED based estimation suggests that the secondary cancer risk from TOMO is less than or comparable to the risks from conventional IMRT and VMAT.

[1]  Nobuyuki Moribe,et al.  Dosimetric properties of radiophotoluminescent glass rod detector in high-energy photon beams from a linear accelerator and cyber-knife. , 2004, Medical physics.

[2]  Cedric X. Yu,et al.  Intensity-modulated arc therapy with dynamic multileaf collimation: an alternative to tomotherapy. , 1995, Physics in medicine and biology.

[3]  S. McKeever,et al.  Studies of PTTL and OSL in TLD-400 , 1990 .

[4]  A R Hounsell,et al.  X-ray leakage considerations for IMRT. , 2001, The British journal of radiology.

[5]  C Clifton Ling,et al.  High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. , 2002, International journal of radiation oncology, biology, physics.

[6]  A Brahme,et al.  Solution of an integral equation encountered in rotation therapy. , 1982, Physics in medicine and biology.

[7]  K. Shin,et al.  Radiation-induced cancers from modern radiotherapy techniques: intensity-modulated radiotherapy versus proton therapy. , 2010, International journal of radiation oncology, biology, physics.

[8]  Dong Wook Kim,et al.  Dose response of commercially available optically stimulated luminescent detector, Al2O3:C for megavoltage photons and electrons. , 2012, Radiation protection dosimetry.

[9]  D Followill,et al.  Estimates of whole-body dose equivalent produced by beam intensity modulated conformal therapy. , 1997, International journal of radiation oncology, biology, physics.

[10]  T R Mackie,et al.  History of tomotherapy , 2006, Physics in medicine and biology.

[11]  B. Min,et al.  Secondary radiation doses of intensity-modulated radiotherapy and proton beam therapy in patients with lung and liver cancer. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[12]  L. Verhey,et al.  Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone. , 1995, International journal of radiation oncology, biology, physics.

[13]  S. Yeh,et al.  Comparison on characteristics of radiophotoluminescent glass dosemeters and thermoluminescent dosemeters. , 2006, Radiation protection dosimetry.

[14]  Daliang Cao,et al.  Comparison of plan quality provided by intensity-modulated arc therapy and helical tomotherapy. , 2007, International journal of radiation oncology, biology, physics.

[15]  Karl Otto,et al.  Volumetric modulated arc therapy: IMRT in a single gantry arc. , 2007, Medical physics.

[16]  P. Jursinic,et al.  Characterization of optically stimulated luminescent dosimeters, OSLDs, for clinical dosimetric measurements. , 2007, Medical physics.

[17]  Barbara Kaser-Hotz,et al.  Estimation of radiation-induced cancer from three-dimensional dose distributions: Concept of organ equivalent dose. , 2005, International journal of radiation oncology, biology, physics.

[18]  U. Schneider,et al.  A simple dose-response relationship for modeling secondary cancer incidence after radiotherapy. , 2005, Zeitschrift fur medizinische Physik.

[19]  R Mohan,et al.  The biological basis and clinical application of three-dimensional conformal external beam radiation therapy in carcinoma of the prostate. , 1994, Seminars in oncology.

[20]  Gary D Fullerton,et al.  Calculation of effective dose from measurements of secondary neutron spectra and scattered photon dose from dynamic MLC IMRT for 6 MV, 15 MV, and 18 MV beam energies. , 2006, Medical physics.

[21]  R. Macklis.  In regards to Hall: intensity-modulated radiation therapy, protons, and the risk of second cancers (Int J Radiat Oncol Biol Phys 2006;65:1-7). , 2006, International journal of radiation oncology, biology, physics.

[22]  R Mohan,et al.  Conformal radiation treatment of prostate cancer using inversely-planned intensity-modulated photon beams produced with dynamic multileaf collimation. , 1996, International journal of radiation oncology, biology, physics.

[23]  E. Piesch,et al.  Photoluminescence Dosimetry: Progress and Present State of Art , 1990 .

[24]  T. Rockwell Mackie,et al.  Helical Tomotherapy: An Innovative Technology and Approach to Radiation Therapy , 2002, Technology in cancer research & treatment.

[25]  T. Schultheiss,et al.  The influence of local control on metastatic dissemination of prostate cancer treated by external beam megavoltage radiation therapy , 1991, Cancer.

[26]  E. Hall,et al.  Radiation-induced second cancers: the impact of 3D-CRT and IMRT. , 2003, International journal of radiation oncology, biology, physics.

[27]  C. Ling,et al.  Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. , 1999, International journal of radiation oncology, biology, physics.

[28]  D P Dearnaley,et al.  Reduction of small and large bowel irradiation using an optimized intensity-modulated pelvic radiotherapy technique in patients with prostate cancer. , 2000, International journal of radiation oncology, biology, physics.

[29]  J. Balog,et al.  Helical tomotherapy radiation leakage and shielding considerations. , 2005, Medical physics.